Loading…
SkinHealth Systems Inc. is projected to decline to $0.6425 by 2027, a -6% move from its current price of $0.6855. SKIN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6532 | $0.6849 | $0.7182 | -0.08% |
| Aug 6 | $0.64 | $0.6844 | $0.7318 | -0.17% |
| Aug 7 | $0.6299 | $0.6838 | $0.7423 | -0.25% |
| Aug 8 | $0.6214 | $0.6832 | $0.7511 | -0.33% |
| Aug 9 | $0.614 | $0.6826 | $0.7589 | -0.42% |
| Aug 10 | $0.6073 | $0.6821 | $0.766 | -0.50% |
| Aug 11 | $0.6012 | $0.6815 | $0.7725 | -0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6012 | $0.6815 | $0.7725 | -0.59% |
| Week 2 | $0.5674 | $0.6775 | $0.8089 | -1.17% |
| Week 3 | $0.5421 | $0.6735 | $0.8369 | -1.75% |
| Week 4 | $0.5211 | $0.6696 | $0.8604 | -2.32% |
| Week 5 | $0.5029 | $0.6657 | $0.8811 | -2.89% |
| Week 6 | $0.4868 | $0.6618 | $0.8997 | -3.46% |
| Week 7 | $0.4722 | $0.6579 | $0.9167 | -4.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SkinHealth Systems Inc. is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The flagship HydraFacial enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc.
in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SkinHealth Systems Inc., symbol SKIN, currently trades at $0.6435 with a market cap of $83.4M and ranks 4267 by market capitalization. The near-term picture shows a bearish tilt and a higher upside potential over the multi-year horizon as captured by the forecast sequence. The longer-run outlook points to higher price levels in the years ahead, with 2030, 2040 and 2050 averages suggesting meaningful upside from the current level.
A major floor 50.1% below — a decisive break under it would weaken the trend.
The nearest floor, 6.6% below — buyers have tended to step in here.
The nearest ceiling, 61.9% above — a clean break opens room to run.
A major ceiling 87.0% above — clearing it would confirm fresh momentum.
Key SKIN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SKIN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6906 | Sell | $0.6928 | Sell |
| MA 10 | $0.723 | Sell | $0.7234 | Sell |
| MA 20 | $0.8137 | Sell | $0.7504 | Sell |
| MA 50 | $0.7344 | Sell | $0.7692 | Sell |
| MA 100 | $0.8223 | Sell | $0.8582 | Sell |
| MA 200 | $1.09 | Sell | $1.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.07 | Neutral |
| Stoch RSI (14) | 22.54 | Neutral |
| CCI (20) | -88.16 | Neutral |
| Williams %R (14) | -83.97 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -24.28 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 16.03 | Buy |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 34.45 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 0.65 | Buy |
| ADX (14) | 13.81 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture shows bearish sentiment, with the RSI14 at 40. The 50-day simple moving average sits at $0.7326, and the 200-day simple moving average at $1.10, indicating a potential hurdle to sustained upside. Support is identified at $0.64 and resistance at $1.11, framing a recent range between the low and high of $0.4656 and $0.8894 over the past 30 days.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.58 | $0.6855 | $0.8703 | 0% | Neutral | |
| $0.4783 | $0.6425 | $0.9297 | -6% | Neutral | |
| $0.4128 | $0.5848 | $0.8978 | -15% | Neutral | |
| $0.4136 | $0.6129 | $0.9845 | -11% | Neutral | |
| $0.5429 | $0.8378 | $1.40 | +22% | Bullish | |
| $0.5593 | $0.896 | $1.54 | +31% | Bullish | |
| $0.5218 | $0.8663 | $1.53 | +26% | Bullish | |
| $0.4661 | $0.8004 | $1.45 | +17% | Neutral | |
| $0.444 | $0.7879 | $1.47 | +15% | Neutral | |
| $0.4979 | $0.9122 | $1.73 | +33% | Bullish | |
| $0.5106 | $1.09 | $2.26 | +59% | Bullish | |
| $1.02 | $2.26 | $5.19 | +229% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.58 | $0.6855 | $0.8334 | +0.00% |
| September 2026 | $0.5288 | $0.6389 | $0.803 | -6.79% |
| October 2026 | $0.5192 | $0.635 | $0.8127 | -0.61% |
| November 2026 | $0.5408 | $0.668 | $0.8673 | +5.19% |
| December 2026 | $0.5308 | $0.6618 | $0.8703 | -0.93% |
Click any year to see its month-by-month SKIN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SKIN price prediction for 2026 points to an average of $0.6855 (low $0.58, high $0.8703) — a potential gain of 0% on today's $0.6855. Price action looks broadly range-bound.
In 2027, SKIN is projected to trade between $0.4783 and $0.9297, averaging $0.6425 — a potential decline of -6% from today's $0.6855. That is -6% versus the projected 2026 average. A consolidation phase looks the most probable path here.
SkinHealth Systems Inc.'s 2028 outlook centres on $0.5848, within a $0.4128 to $0.8978 range. That is -9% versus the projected 2027 average. That marks a -15% change versus current levels. Price action looks broadly range-bound.
By 2029, SKIN could reach as high as $0.9845, with a base case around $0.6129 and support toward $0.4136 — roughly -11% from $0.6855. A consolidation phase looks the most probable path here.
Expect SKIN to range from $0.5429 to $1.40 through 2030. The $0.8378 average target implies a +22% move from current prices. That is up +37% on the projected 2029 average. Momentum favours further upside here.
The SKIN price prediction for 2031 points to an average of $0.896 (low $0.5593, high $1.54) — a potential gain of +31% on today's $0.6855. Buyers look set to stay in control over this stretch.
In 2032, SKIN is projected to trade between $0.5218 and $1.53, averaging $0.8663 — a potential gain of +26% from today's $0.6855. That is -3% versus the projected 2031 average. Momentum favours further upside here.
SkinHealth Systems Inc.'s 2033 outlook centres on $0.8004, within a $0.4661 to $1.45 range. That is -8% versus the projected 2032 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2034, SKIN could reach as high as $1.47, with a base case around $0.7879 and support toward $0.444 — roughly +15% from $0.6855. Price action looks broadly range-bound.
Expect SKIN to range from $0.4979 to $1.73 through 2035. The $0.9122 average target implies a +33% move from current prices. That is up +16% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The SKIN price prediction for 2040 points to an average of $1.09 (low $0.5106, high $2.26) — a potential gain of +59% on today's $0.6855. Momentum favours further upside here.
In 2050, SKIN is projected to trade between $1.02 and $5.19, averaging $2.26 — a potential gain of +229% from today's $0.6855. That is up +107% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SKIN today (≈ 1,458.789205 SKIN) could be worth
$3,290.58
+$2,290.58 (+229%) by 2050 · US Dollar
Based on the average projected SKIN price of $2.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SKINwould be worth at today's price.
$1,000 invested in SKIN on Jul 31, 2025 (≈ 649.350665 SKIN) would be worth
$445.13
-$554.87 (-55.5%) today · 0.45× · US Dollar
Based on a SKIN entry price of $1.54 vs. today's $0.6855.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.732 | $936.48 | -6.4% |
| 1 month ago | $0.718 | $954.74 | -4.5% |
| 3 months ago | $0.863 | $794.32 | -20.6% |
| 6 months ago | $1.5 | $457 | -54.3% |
| 1 year ago | $1.54 | $445.13 | -55.5% |
| All time (5.0y) ago | $18.5 | $37.05 | -96.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SKIN forecast.
Our base-case forecast reaches $1.40 around 2050.
Implied market cap at $1.40: $181.44M
The multi-year forecast paints a mixed but progressively improving path. In 2030 the average price is forecast at $0.7695 with a 19.6 ROI and a neutral sentiment. Earlier, 2031 shows an average of $0.8266 with a 28.5 ROI and bullish sentiment, followed by 2032 with an average of $0.7857 and a 22.1 ROI.
By 2040 the average rises to $0.9782 with a 52 ROI and bullish sentiment, and by 2050 the average is $2.02 with a 213.3 ROI and bullish sentiment. The 2027-2029 window contains negative ROI readings (-7.3, -15.9, -14.2 respectively) and neutral to bearish sentiment, highlighting near-term risk. Overall, the forecast implies meaningful upside potential over the longer horizon, but with notable near-term volatility and downside risk in some years.
Tap a question to reveal the answer.
2030: min $0.4923, avg $0.7695, max $1.30; ROI 19.6; sentiment NEUTRAL.
Near-term readings show mixed prospects, with 2027 ROI -7.3, 2028 ROI -15.9, 2029 ROI -14.2 and neutral to bearish sentiment in earlier years, before turning bullish later in the forecast.
Yes. The 2035 forecast shows a max of $1.56, which includes a potential reach of $1.50.
Bearish sentiment with RSI14 40, SMA50 $0.7326, SMA200 $1.10, support $0.64, resistance $1.11. The 30-day range runs from $0.4656 to $0.8894.
Current price $0.6435 and market cap $83.4M, with a rank of 4267.
SkinHealth Systems Inc. Community Discussion
0Share your SkinHealth Systems Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.